Prof. Dr. Khairy Mohamed Abdalla Zoheir | Medicinal Chemistry | Best Researcher Award
National Research Centre, Egypt
👨🎓Profiles
🎓 Early Academic Pursuits
Dr. Khairy Mohamed Abdalla Zoheir began his distinguished academic journey with a focus on genetics, cytology, and histology. He earned both his Ph.D. and MD from Cairo University, Egypt, in July 2005. His early research laid the foundation for his future work in animal genetics and molecular biology. In pursuit of advanced knowledge, Dr. Zoheir received a two-year postdoctoral fellowship at the College of Science and Technology, Huazhong Agricultural University, Wuhan, China (2006–2008), where he deepened his expertise in cutting-edge genetic research.
💼 Professional Endeavors
Dr. Zoheir has built an illustrious career as a Professor of Animal Genetics at the Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt. His international experience includes a tenure as Assistant Professor of Pharmacology and Toxicology at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, from 2009 onward. Through these roles, he has contributed significantly to advancing the understanding of gene therapy and pharmacology, cementing his place as a leader in his field.
🧬 Contributions and Research Focus
Dr. Zoheir’s research revolves around RNA interference (RNAi), overexpression studies, epigenetics, and gene therapy for diseases such as cancer. His groundbreaking work extends to novel therapeutic approaches, including the development of an internationally patented anti-inflammatory topical gel containing myrrh extract (2016). His research findings also highlight the role of lipoic acid in modulating cytokines, thereby influencing wound healing. With 92 publications in SCI and Scopus-indexed journals, his contributions have significantly impacted the fields of molecular biology and pharmacology.
🌟 Impact and Influence
Dr. Zoheir’s work has garnered widespread recognition in both national and international scientific communities. His research funding achievements and numerous conference presentations underscore his commitment to knowledge dissemination and collaboration. He has authored 85 publications in prestigious journals, influencing emerging fields such as epigenetics and gene therapy. Additionally, his editorial appointment with Frontiers in Molecular Biosciences showcases his leadership in shaping the future of molecular biology research.
📚 Academic Cites and Publications
With a total of 92 SCI-indexed and Scopus-indexed publications, Dr. Zoheir has made a lasting impact on the scientific world. His work continues to be cited by peers worldwide, further establishing his reputation as a prolific researcher in molecular genetics, RNAi, and gene therapy.
🛠️ Technical Skills
Dr. Zoheir is adept in advanced molecular biology techniques such as RNA interference, gene overexpression, and epigenetics. His expertise also includes pharmacological studies and the development of novel therapeutic formulations, exemplified by his internationally patented myrrh-based topical gel.
🧑🏫 Teaching Experience
Throughout his career, Dr. Zoheir has demonstrated a passion for education. He has mentored numerous students and researchers, fostering their growth in genetics and molecular biology. His teaching roles at the National Research Centre and King Saud University have helped train the next generation of scientists and researchers.
🌍 Legacy and Future Contributions
Dr. Zoheir’s legacy is marked by his innovative research, impactful publications, and commitment to advancing molecular biology. As a pioneer in RNAi and gene therapy, he continues to inspire researchers worldwide. His future contributions are expected to further unravel the complexities of epigenetics and therapeutic interventions, leaving an indelible mark on the scientific community.
📖Notable Publications
-
Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives
- Authors: Sroor, F.M., Tohamy, W.M., Zoheir, K.M.A., Mahrous, K.F., Ibrahim, N.S.
- Journal: BMC Chemistry
- Year: 2023
-
Naringin–Dextrin Nanocomposite Abates Diethylnitrosamine/Acetylaminofluorene-Induced Lung Carcinogenesis by Modulating Oxidative Stress, Inflammation, Apoptosis, and Cell Proliferation
- Authors: Mohamed, E.E., Ahmed, O.M., Zoheir, K.M.A., Bishayee, A., Abdel-Moneim, A.
- Journal: Cancers
- Year: 2023
-
The anticarcinogenic effect of eugenol on lung cancer induced by diethylnitrosamine/2-acetylaminofluorene in Wistar rats: insight on the mechanisms of action
- Authors: Morsy, H.M., Ahmed, O.M., Zoheir, K.M.A., Abdel-Moneim, A.
- Journal: Apoptosis
- Year: 2023
-
Mesenchymal Stem Cells and Begacestat Mitigate Amyloid-β 25–35-Induced Cognitive Decline in Rat Dams and Hippocampal Deteriorations in Offspring
- Authors: Gaber, A., Ahmed, O.M., Khadrawy, Y.A., Alblihed, M.A., Elbakry, A.M.
- Journal: Biology
- Year: 2023
-
Anticancer Activity of New Bis-(3-(Thiophen-2-yl)-1H-Pyrazol-4-yl)Chalcones: Synthesis, in-Silico, and in-Vitro Studies
- Authors: Sroor, F.M., Mohamed, M.F., Abdullah, G.K., Elwahy, A.H.M., Abdelhamid, I.A.
- Journal: Polycyclic Aromatic Compounds
- Year: 2023
-
Protective Effects of Naringin–Dextrin Nanoformula against Chemically Induced Hepatocellular Carcinoma in Wistar Rats: Roles of Oxidative Stress, Inflammation, Cell Apoptosis, and Proliferation
- Authors: Mohamed, E.E., Ahmed, O.M., Abdel-Moneim, A., Hassaballa, A., El-Shahawy, A.A.G.
- Journal: Pharmaceuticals
- Year: 2022